Sara Kenkare-Mitra's Net Worth
$1.83 Million
Who is Sara Kenkare-Mitra?
Sara Kenkare-Mitra has an estimated net worth of $1.83 Million. This is based on reported shares across multiple companies, which include Alector, Inc., and Unicycive Therapeutics, Inc..
SEC CIK
Sara Kenkare-Mitra's CIK is 0001895592
Past Insider Trading and Trends
2022 was Sara Kenkare-Mitra's most active year for acquiring shares with 5 total transactions. Sara Kenkare-Mitra's most active month to acquire stocks was the month of September. 2023 was Sara Kenkare-Mitra's most active year for disposing of shares, totalling 4 transactions. Sara Kenkare-Mitra's most active month to dispose stocks was the month of February. 2022 saw Sara Kenkare-Mitra paying a total of $0.00 for 551,941 shares, this is the most they've acquired in one year. In 2023 Sara Kenkare-Mitra cashed out on 32,949 shares for a total of $214,349.45, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Alector, Inc. (ALEC) Snapshot price: $4.85
President and Head R&DSara Kenkare-Mitra owns 291,715 units of Common Stock which is worth $1,414,817.75. From 2021 to 2024 Sara Kenkare-Mitra acquired a total of 361,965 shares in Alector, Inc., Sara also disposed a total of 70,250 shares of Alector, Inc. equalling to $416,090.33.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -4.56% | -13.93K |
$4.88 | -$67,981.16 | 291.71K |
Sep 3
| |||
Form 4
| -4.14% | -13.21K |
$4.80 | -$63,372.95 | 305.64K |
Jun 3
| |||
Form 4
| -3.09% | -10.17K |
$6.92 | -$70,386.77 | 318.85K |
Mar 4
| |||
Form 4
| -3.67% | -12.52K |
$5.56 | -$69,605.64 | 329.02K |
Dec 4
| |||
Form 4
| +91.94% | 163.6K |
—
|
—
| 341.54K |
Oct 1
| |||
Form 4
| -3.37% | -6.21K |
$5.19 | -$32,277.38 | 177.94K |
Sep 5
| |||
Form 4
| -2.17% | -4.09K |
$6.90 | -$28,249.94 | 184.15K |
Jun 2
| |||
Form 4
| -5.10% | -10.12K |
$8.32 | -$84,216.49 | 188.24K |
Mar 2
| |||
Form 4
| +68.11% | 80.36K |
—
|
—
| 198.37K |
Oct 1
| |||
Form 4
|
∞
| 118K |
—
|
—
| 118K |
Jan 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Unicycive Therapeutics, Inc. (UNCY) Snapshot price: $0.35
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||